School of Medicine
Showing 651-700 of 742 Results
-
Kristina Kudelko
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsDrugs and toxins-associated pulmonary arterial hypertension, clinical outcomes research, evaluating the long-term impacts of a standardized pulmonary vascular disease fellowship training program
-
Ellen Kuhl
Catherine Holman Johnson Director of Stanford Bio-X, Walter B Reinhold Professor in the School of Engineering, Professor of Mechanical Engineering and, by courtesy, of Bioengineering
Current Research and Scholarly Interestscomputaitonal simulation of brain development, cortical folding, computational simulation of cardiac disease, heart failure, left ventricular remodeling, electrophysiology, excitation-contraction coupling, computer-guided surgical planning, patient-specific simulation
-
Andre Kumar MD, MEd
Clinical Associate Professor, Medicine
BioDr. Andre Kumar is a Clinical Associate Professor in the Stanford Division of Hospital Medicine with a passion for improving patient care through Point-of-Care Ultrasound (POCUS), clinical research, and education. He earned his MD from Tulane University and completed his residency, chief residency, and a Master's in Education at Stanford University.
Dr. Kumar has extensive experience in creating, operationalizing, and leading multi-center clinical trials, including investigations related to POCUS, COVID-19 therapeutics, procedural safety, and the long-term health consequences of infections on the heart and lungs. He continues to conduct research and teach POCUS on a local and national level, and is committed to improving the science and education that underlie the next generation of diagnostic tools. Currently, his research focuses on the impact of artificial intelligence (AI) on numerous healthcare applications, particularly for the improving the accuracy of clinician diagnosis, evidence-based management, and medical imaging.
Dr. Kumar is also a committed educator and mentor to the next generation of physicians. His contributions to medical education have been recognized with several awards, including the Lawrence H. Mathers Award for Exceptional Commitment to Teaching (2023), the Henry J. Kaiser Foundation Award for Excellence in Clinical Teaching (2018, 2022), and the David A. Rytand Clinical Teaching Award (2018, 2022, and 2025). Dr. Kumar has contributed to the creation of educational content, including videos for the Stanford Medicine 25 series that cover various aspects of POCUS.
Dr. Kumar has held numerous leadership positions that reflect his commitment to advancing medical education and clinical practice. He is the Director of the Rathmann Fellowship in Medical Education at Stanford University. In the School of Medicine, he serves as the Co-Director of Clinical Reasoning and Associate Course Director for the Practice of Medicine course. Dr. Kumar is also the Director of the SMART-HM Program, which focuses on faculty development. He is also the Co-Founder and Director of the SHAPE Program in the Stanford Internal Medicine Residency Program.
List of publications: https://bit.ly/3eop95i
ClinicalTrials.Gov registration:
https://bit.ly/2TizOmD
https://bit.ly/2zeNBjJ
Media:
https://shorturl.at/rNU46
https://stanfordmedicine.box.com/s/jm3544zdwpihj6bstcv72x76zq9nuzbq
https://bit.ly/33MZa0O
https://bit.ly/3t8HE2u
https://wb.md/2zfjY1N -
Manoj Kumar
Postdoctoral Scholar, Radiology
Current Research and Scholarly InterestsAntibody discovery and characterization | Targeted delivery of genes and drugs | mRNA
therapeutics | Immuno-oncology | CAR-T engineering | Immune profiling | PET/MR imaging -
Parth I Kumar
Affiliate, Department Funds
Fellow in Medicine - Med/NephrologyBioParth Kumar is a fellow in the Stanford University Nephrology Fellowship Program. Dr. Kumar holds a B.A. in Molecular and Cell Biology from UC Berkeley and an M.D. with Distinction from UCSF School of Medicine. He completed his Internal Medicine Residency at UC Irvine, where he was recognized as the Intern Teacher of the Year in 2022. Dr. Kumar's research interests span health care innovation and translational medicine, such as integrating 3D printing into clinical settings to aid patient education, evaluating novel medical devices. His past work includes the study "Evaluating the use of Radioactive Analogs of Doxorubicin for Quantifying ChemoFilter binding and Whole Body PET/MRI Biodistribution," leading to him being recognized as one of the JVIR Editor's Honorees: Distinguished Laboratory Investigations in 2022.
-
Karteek Kunala
Research Engineer, Ophthalmology Research/Clinical Trials
BioMy current interests are in development of design and instrumentation of pre-clinical vision devices, to conduct non-invasive in vivo retinal imaging. I studied Physics with a concentration in optics during my time at University of Hyderabad, India and received a bachelors and masters degree in 2014. I then moved to USA to continue working in the field of optics at University of North Carolina at Charlotte to pursue my PhD, working on nanofabrication of broadband anti-reflective structures. My interest in vision science started with my job at University of Rochester as a research scientist, where I was involved in developing optical imaging tools using adaptive optics to study retinal diseases. My work was focused on development of fluorescence lifetime imaging techniques in humans and two photon fluorescence microscopy in mouse.
-
Anshul Kundaje
Associate Professor of Genetics and of Computer Science
Current Research and Scholarly InterestsWe develop statistical and machine learning frameworks to model gene regulation and decipher the genetic and molecular basis of disease
-
Christian Kunder
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy main interest is in understanding the biology of human neoplasms, using traditional histopathology, molecular genetic techniques, and other modalities. In particular, I am interested in soft tissue and genitourinary neoplasms, especially prostate cancer.
I am also interested in the classification and nomenclature of neoplasms and in practical research that helps us refine these, using a variety of techniques but still principally guided by histopathology.
I also work on developing next generation sequencing-based tests for genotyping tumors and in expanding the scope of this testing with the goal of identifying patients eligible for novel targeting therapies.
